Heart rate variability is related to disease activity and smoking in rheumatoid arthritis patients

International Journal of Clinical Practice

Volumn 61, Issue 5, 2007, Pages 777-783

  Anichkov, D A ^a   Shostak, N A ^a   Ivanov, D S ^a  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; JOINT SWELLING; LEUKOCYTE COUNT; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SAMPLE SIZE; SCORING SYSTEM; SMOKING;

ADOLESCENT; ADULT; AGED; ARRHYTHMIA; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; HEART RATE; HUMANS; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SMOKING;

EID: 34247103102     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01099.x     Document Type: Article

References (44)

1. del Rincon I, Williams K, Stern MP et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
2. Jacobsson LT, Turesson C, Hansson RL et al. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum 2001; 44: 1170-6.
3. Goodson NJ, Wiles NJ, Lunt M et al. Mortality in early seropositive polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002; 46: 2010-9.
4. Solomon DH, Karlson EW, Rimm EB et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 1303-7.
5. Maradit-Kremers H, Crowson CS, Nicola PJ et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005; 52: 402-11.
6. Tsuji H, Larson MG, Venditti FJ Jr et al. Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study. Circulation 1996; 94: 2850-5.
7. Huikuri HV, Jokinen V, Syvanne M et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999; 19: 1979-85.
8. Hohnloser SH, Klingenheben T, Zabel M, Li YG. Heart rate variability used as an arrhythmia risk stratifier after myocardial infarction. Pacing Clin Electrophysiol 1997; 20: 2594-601.
9. Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1999; 33: 1203-7.
10. Evrengul H, Dursunoglu D, Cobankara V et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 2004; 24: 198-202.
11. Conroy RM, Pyorala K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
12. van der Heijde DM, van't Hof MA, van Riel PL et al. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 1992; 51: 177-81.
13. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-81.
14. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005; 10: 88-101.
15. Niskanen JP, Tarvainen MP, Ranta-Aho PO, Karjalainen PA. Software for advanced HRV Analysis. Comput Methods Programs Biomed 2004; 76: 73-81.
16. Lombardi F. Clinical implications of present physiological understanding of HRV components. Card Electrophysiol Rev 2002; 6: 245-9.
17. Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J Intern Med 2005; 257: 156-66.
18. Sajadieh A, Nielsen OW, Rasmussen V et al. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004; 25: 363-70.
19. Janszky I, Ericson M, Lekander M et al. Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 2004; 256: 421-8.
20. Baerwald CG, Laufenberg M, Specht T et al. Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors. Br J Rheumatol 1997; 36: 1262-9.
21. Dekkers JC, Geenen R, Godaert GL et al. Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 2004; 22: 63-70.
22. Straub RH, Harle P. Sympathetic neurotransmitters in joint inflammation. Rheum Dis Clin North Am 2005; 31: 43-59.
23. Gerli R, Sherer Y, Vaudo G et al. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann N Y Acad Sci 2005; 1051: 281-90.
24. Chung CP, Oeser A, Raggi P et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 2005; 52: 3045-53.
25. Goodson NJ, Silman AJ, Pattison DJ et al. Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis. Rheumatology (Oxford) 2004; 43: 731-6.
26. Papadopoulos NG, Alamanos Y, Voulgari PV et al. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 2005; 23: 861-6.
27. Davis JM III, Maradit-Kremers H, Gabriel SE. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect? J Rheumatol 2005; 32: 1856-62.
28. Kamen PW, Krum H, Tonkin AM. Poincare plot of heart rate variability allows quantitative display of parasympathetic nervous activity in humans. Clin Sci (Lond) 1996; 91: 201-8.
29. Huikuri HV, Seppanen T, Koistinen MJ et al. Abnormalities in beat-to-beat dynamics of heart rate before the spontaneous onset of life-threatening ventricular tachyarrhythmias in patients with prior myocardial infarction. Circulation 1996; 93: 1836-44.
30. Stein PK, Domitrovich PP, Huikuri HV et al. Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction. J Cardiovasc Electrophysiol 2005; 16: 13-20.
31. Umetani K, Singer DH, McCraty R, Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol 1998; 31: 593-601.
32. Antelmi I, de Paula RS, Shinzato AR et al. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am J Cardiol 2004; 93: 381-5.
33. Ramaekers D, Ector H, Aubert AE et al. Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective? Eur Heart J 1998; 19: 1334-41.
34. Stein PK, Kleiger RE, Rottman JN. Differing effects of age on heart rate variability in men and women. Am J Cardiol 1997; 80: 302-5.
35. Sandhu V, Allen SC. The effects of age, seropositivity and disease duration on autonomic cardiovascular reflexes in patients with rheumatoid arthritis. Int J Clin Pract 2004; 58: 740-5.
36. Ziegler D, Piolot R, Strassburger K et al. Normal ranges and reproducibility of statistical, geometric, frequency domain, and non-linear measures of 24-hour heart rate variability. Horm Metab Res 1999; 31: 672-9.
37. Dessein PH, Joffe BI. When is a patient with rheumatoid arthritis at risk for cardiovascular disease? J Rheumatol 2006; 33: 201-3.
38. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-63.
39. Vaudo G, Marchesi S, Gerli R et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004; 63: 31-5.
40. Dessein PH, Joffe BI, Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2005; 7: R634-43.
41. Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology (Oxford) 2005; 44: 1473-82.
42. Van Doornum S, Jennings GL, Wicks IP. Reducing the cardiovascular disease burden in rheumatoid arthritis. Med J Aust 2006; 184: 287-90.
43. Lombardi F. Sympathetic activation and sub-clinical inflammation: a new combination to identify high-risk subjects. Eur Heart J 2004; 25: 359-60.
44. Shehab AM, MacFadyen RJ, McLaren M et al. Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart 2004; 90: 1263-8.